4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001567619-18-002811
CEO sold 29,539 shares at $65.00 ($1,920,035)
- CEO acquired 29,539 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Abdun-Nabi Daniel CEO | 2018-09-14 | Option exercise | +28,220 | $13.38 | $377,584 | 194,787 | D: show line 1 in the form |
| Abdun-Nabi Daniel CEO | 2018-09-14 | Sale | −28,220 | $65.00 | $1,834,300 | 166,567 | D: show line 2 in the form |
| Abdun-Nabi Daniel CEO | 2018-09-17 | Option exercise | +1,319 | $13.38 | $17,648 | 167,886 | D: show line 3 in the form |
| Abdun-Nabi Daniel CEO | 2018-09-17 | Sale | −1,319 | $65.00 | $85,735 | 166,567 | D: show line 4 in the form |
| Open-market sales · 29,539 sh · avg $65.00 · $1,920,035 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Abdun-Nabi Daniel CEO | 2018-09-14 | Option exercise · Stock Option (Right to Buy) | +28,220 | 1,319 | D: show line 5 in the form | ||
| Abdun-Nabi Daniel CEO | 2018-09-17 | Option exercise · Stock Option (Right to Buy) | +1,319 | 0 | D: show line 6 in the form |
Loading xslF345X03/doc1.xml…